Perineural Methylene Blue Infusion in Lower Limb Amputation Surgery

NARecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

August 1, 2026

Study Completion Date

May 1, 2027

Conditions
PerineuralMethylene BlueLower Limb Amputation
Interventions
DRUG

Bupivacaine methylene blue

"Patients in this group will receive the following regimen through the perineural catheter:~Bolus dose of 1 ml methylene blue 1% (10 mg) plus 19 ml bupivacaine 0.25% will be given intraoperatively before wound closure, and perineural infusion of methylene blue plus bupivacaine 0.25% (1 ml of methylene blue added to each 49 ml of bupivacaine 0.25%) will be started in the recovery room at a rate of 2-5 ml/hour for 72 hours postoperatively"

DRUG

bupivacaine saline

"Patients in this group will receive the following regimen through the perineural catheter:~Bolus dose of 1 ml normal saline plus 19 ml bupivacaine 0.25% will be given intraoperatively before wound closure, and perineural infusion of bupivacaine 0.25% will be started in the recovery room at a rate of 2-5 ml/hour for 72 hours postoperatively"

Trial Locations (1)

31527

RECRUITING

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER